Researcher shines light on the search for new drugs

June 25, 2014, Medical College of Georgia
Dr. Nevin Lambert is a biophysicist at the MCG at Georgia Regents University. Credit: Phil Jones

They are the largest family of receptors on the surface of our cells, and they help us maintain basics like blood pressure and heart rate.

These important day jobs make G protein-coupled receptors natural targets for drugs that can lower or dilate an airway, scientists say. In fact, of all the drugs out there, nearly half act by first sticking to a G , said Dr. Nevin Lambert, biophysicist at the Medical College of Georgia at Georgia Regents University.

However, just how many targets the receptors offer remains a much-debated issue.

"If you imagine opening a box and finding a whole bunch of new drug targets that nobody has found before, that would be cool, and you have lots more ways to change things," Lambert said.

If such a treasure trove sounds too good to be true, Lambert suspects it probably is. He just received a $900,000 grant from the National Institutes of Health's National Institute of General Medical Sciences that is enabling him to resolve the hotly debated issue in new .

The math already looks good, with about 350 G protein-coupled receptors involved in a myriad of basic physiological functions that might need adjusting to improve health. In fact, a single receptor can be a target for multiple agents found in nature and drugstores. But, for nearly two decades, the potential has been even more enticing.

In addition to being a high-functioning single molecule, it's widely held that two G protein-coupled receptors regularly chemically bind, creating what's termed a dimer, which has a whole different function than the two individual receptors.

"If this is true, then the potential for future drug discovery would be immense," Lambert said.

Drug companies have an obvious interest in the possibilities, but the reality has not panned out.

"The real question is: How many drug targets are there? Are there a few hundred or thousands? We are testing that question, basically." Lambert suspects that surprisingly few have appeared because the receptors might not actually be dimers.

Receptors are constantly scurrying around the and wiggling like a Slinky toy. When scientists have looked at them, primarily with a technique called luminescence energy transfer, which uses the natural glow of a sea pansy protein to light up a receptor, the thinking has been that if another receptor is close enough to bask in its glow, the two have formed a dimer.

Lambert suspects that light transfer is really a matter of random proximity for a few fractions of a second by the constantly moving receptors. "It's in the light, but it can be by chance," he said.

To definitively answer whether these are real or accidental relationships, Lambert is adding a little more light. He is still using the sea pansy protein to give some receptors a blue glow; he's also fusing a yellow fluorescent jelly-fish protein to others. While he knows there will still be lots of energy transfer as the receptors scuttle about, Lambert is looking at the distance between yellow and blue receptors as the total number of receptors changes. If the blue and yellow receptors are not dimers, he expects the distance between them to shrink because there is simply less room. If actual dimers are forming, the minute distance between the receptors won't and really can't change as the crowd thickens. He's repeating this process in a lot of different cell types and tissues.

The issue of whether G protein-coupled receptors form dimers needs resolving, Lambert said, because, while he and others like the notion of thousands of additional treatment targets for a host of ailments, searches based on a false premise waste research resources.

Lambert also recently received a second NIGMS grant to better define these receptors' relationships with G proteins, from which they get their name and their ability to take action.

While it's interesting science, this question also gets back to the issue of maximizing drug development, Lambert said. Do receptors carry their own G protein around with them that they interact with when stimulated by a hormone or drug, or can they interact with a wide range of G proteins?

He'll be looking at some of the same receptors, but this time, in collaboration with researchers at Columbia University in New York, he'll look at individual receptors in real time to see whether, as they move around the cell surface, a protein is traveling with them just below the cell surface. Or, do these receptors travel independently and couple with a G protein floating inside the cell only when activated?

This time he suspects a one-on-one relationship. "The question is, does one receptor stick to one G protein for a really long period of time or do they just bounce off each other very quickly?" The ability to analyze one molecule at a time should yield the answer.

Lambert notes that humans have some 600 additional G protein-coupled receptors involved in the sense of smell; dogs have thousands. The number involved in other physiological functions reflects the body's complexity, with humans having about 350, and some plants having just one.

In addition to helping scientists see , sea pansies, an animal related to sea jellies, create some of the sparkles and flashes visible in the ocean at night.

Explore further: Study: Prazosin inhibits endocytic sorting

Related Stories

Study: Prazosin inhibits endocytic sorting

September 13, 2012
In a study just published in Proceedings of the National Academy of Sciences, Dr Ulrike Eggert et al. demonstrated that the drug Prazosin inhibits endocytic sorting.

Switching off anxiety with light

April 7, 2014
Receptors for the messenger molecule serotonin can be modified in such a way that they can be activated by light. Together with colleagues, neuroscientists from the Ruhr-Universität Bochum (RUB) report on this finding in ...

Height protein could be cancer and diabetes treatment target

May 16, 2014
University of Queensland scientists have discovered that a protein that regulates how tall you grow could be used in treating diseases including cancer and diabetes.

New clue to autism found inside brain cells

March 26, 2014
The problems people with autism have with memory formation, higher-level thinking and social interactions may be partially attributable to the activity of receptors inside brain cells, researchers at Washington University ...

Stress hormone receptors localized in sweet taste cells

June 3, 2014
According to new research from the Monell Center, receptors for stress-activated hormones have been localized in oral taste cells responsible for detection of sweet, umami, and bitter. The findings suggest that these hormones, ...

Recommended for you

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.